NAS:SXTP (USA)
Â
Units(1 ord,1 wr & 1 Non Tr)
$
1.86
+0.090 (+5.08%)
07:08 PM EST
What is a stock summary page? Click here for an overview.
Business Description
60 Degrees Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US83006G1040
Share Class Description:
SXTP: Units(1 ord,1 wr & 1 Non Tr)Description
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 31.92 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -8.72 | |||||
| Beneish M-Score | -15.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -45.3 | |||||
| 3-Year EBITDA Growth Rate | -80.7 | |||||
| 3-Year EPS without NRI Growth Rate | -1.5 | |||||
| 3-Year FCF Growth Rate | -202.2 | |||||
| 3-Year Book Growth Rate | 35.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 68.95 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 138.52 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.33 | |||||
| 9-Day RSI | 45.42 | |||||
| 14-Day RSI | 41.22 | |||||
| 3-1 Month Momentum % | -67.88 | |||||
| 6-1 Month Momentum % | -68.82 | |||||
| 12-1 Month Momentum % | -86.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.26 | |||||
| Quick Ratio | 4.92 | |||||
| Cash Ratio | 3.83 | |||||
| Days Inventory | 420.15 | |||||
| Days Sales Outstanding | 189.77 | |||||
| Days Payable | 428.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 405.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.73 | |||||
| Operating Margin % | -1899.2 | |||||
| Net Margin % | -1576.69 | |||||
| FCF Margin % | -860.56 | |||||
| ROE % | -142.88 | |||||
| ROA % | -106.78 | |||||
| ROIC % | -231.54 | |||||
| 3-Year ROIIC % | -115.24 | |||||
| ROC (Joel Greenblatt) % | -318.61 | |||||
| ROCE % | -141.24 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.63 | |||||
| EV-to-EBIT | -0.91 | |||||
| EV-to-EBITDA | -0.92 | |||||
| EV-to-Revenue | 14.43 | |||||
| EV-to-Forward-Revenue | 9.11 | |||||
| EV-to-FCF | -1.75 | |||||
| Price-to-Net-Cash | 0.19 | |||||
| Earnings Yield (Greenblatt) % | -109.89 | |||||
| FCF Yield % | -157.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SXTP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
60 Degrees Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.502 | ||
| EPS (TTM) ($) | -49.86 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 101.25 | ||
| 14-Day RSI | 41.22 | ||
| 14-Day ATR ($) | 0.295449 | ||
| 20-Day SMA ($) | 1.7965 | ||
| 12-1 Month Momentum % | -86.86 | ||
| 52-Week Range ($) | 1.41 - 35.993999 | ||
| Shares Outstanding (Mil) | 1.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
60 Degrees Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
60 Degrees Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
60 Degrees Pharmaceuticals Inc Frequently Asked Questions
What is 60 Degrees Pharmaceuticals Inc(SXTP)'s stock price today?
The current price of SXTP is $1.86. The 52 week high of SXTP is $35.99 and 52 week low is $1.41.
When is next earnings date of 60 Degrees Pharmaceuticals Inc(SXTP)?
The next earnings date of 60 Degrees Pharmaceuticals Inc(SXTP) is .
Does 60 Degrees Pharmaceuticals Inc(SXTP) pay dividends? If so, how much?
60 Degrees Pharmaceuticals Inc(SXTP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers